Implant Sciences to Exhibit at Passenger Terminal Expo 2015 in Paris, France on March 10 - 12, 2015
Share:
Robust market for ETDs in Europe's aviation security market where QS-B220 is the only ECAC-approved ETD with a non-radioactive source for air cargo screening
WILMINGTON, Mass. – Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the Company will exhibit its QS-B220 desktop explosives trace detector at booth #3090 on March 10 - 12, 2015 at the Passenger Terminal Expo 2015 in Paris, France.
The QS-B220 was the first ETD to successfully pass the European Civil Aviation Conference's (ECAC) Common Evaluation Process of Security Equipment for airport checkpoint screening of passengers in October 2014. It is also the first and only ETD with a non-radioactive source to have received approval for air cargo screening in the 44 member nations of ECAC.
"Demand for high-performance ETDs in Europe's aviation and air cargo security sector is higher than we have seen in the recent past. This demand is driven by new regulations for security and higher standards for ETD performance. As the only ECAC-approved ETD with a non-radioactive source for cargo screening, we believe the QS-B220 is extremely well positioned to be a system of choice for European airlines and cargo facilities that prefer security equipment that does not utilize radiation," stated Dr. Darryl Jones, Implant Sciences' Vice President of Global Sales and Marketing.
About the QS-B220 Desktop Explosives and Drugs Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company's team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. The Company's ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China. It also received a GSN 2013 Homeland Security Award for "Best Explosives Detection Solution". All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.
Contact:
Implant Sciences Corporation
Company Contact:
Mike Turmelle, Director
978-752-1700 x 116Â Â Â Â
Source
Implant Sciences Corporation
Web Site: http://www.implantsciences.com
